Results 101 to 110 of about 15,923 (217)

Use Patterns of Novel Janus Kinase Inhibitors After the First Safety Alerts: A Nationwide Register‐Based Time Series Analysis

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Purpose Janus kinase inhibitors (JAKi) are medicines used to treat inflammatory rheumatic musculoskeletal diseases (IRMDs) and inflammatory bowel diseases (IBDs). In Europe, JAKis received marketing authorisation in 2017 for rheumatoid arthritis.
Jarno Rutanen, Pekka Heino, Kati Sarnola, Terhi Kurko   +3 more
wiley   +1 more source

Current Challenges in Managing SpA

Journal of Clinical Rheumatology and Immunology
Managing spondyloarthritis (SpA) presents several complex challenges that impact patient outcomes. One of the foremost issues is the delay in diagnosis, often due to overlapping symptoms with other conditions and insufficient awareness among clinicians ...
Georg Schett
doaj   +1 more source

Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis

RMD Open, 2019
Objective Spondyloarthritis (SpA) can encompass axial, peripheral and extra-articular disease manifestations. Patients are classified as axial or peripheral SpA depending on the presence or absence of current back pain, independently of the other disease
Janneke J de Winter, Jacqueline E Paramarta, Henriëtte M de Jong, Marleen G van de Sande, Dominique L Baeten   +4 more
doaj   +1 more source

Association of Body Mass Index with SARS‐CoV‐2 Infection in Inflammatory Arthritis Patients Receiving Biologic Therapy: Singapore National Biologics Register Findings

International Journal of Rheumatic Diseases, Volume 29, Issue 6, June 2026.
ABSTRACT Purpose To determine the association of body mass index (BMI) with incident COVID‐19 infection in patients with inflammatory arthritis (IA) using biologic disease‐modifying anti‐rheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) and to describe characteristics of patients with severe COVID‐19 infection. Methods This prospective
Preeti Dhanasekaran, Siaw Ing Yeo, Yi Xin Ng, Rosa Lim, Stephanie Wong, Stanley Angkodjojo, Andrew Yu Keat Khor, Li Wearn Koh, Manjari Lahiri, Margaret Ma   +9 more
wiley   +1 more source

Assessing the Impact of Crohn's Disease on Foot Health‐Related Quality of Life: A Case–Control Study

International Wound Journal, Volume 23, Issue 6, June 2026.
ABSTRACT Crohn's disease (CD) is primarily characterised by chronic gastrointestinal inflammation; however, its systemic nature frequently leads to musculoskeletal complications. Among these, clinically significant foot pathologies can impair mobility and negatively impact patients' overall quality of life.
Juan Manuel Escudero‐Prados, Antonio Cortés‐Rodríguez, Ana Júlia Monteiro, Marta E. Losa‐Iglesias, Juan Gómez‐Salgado, Ricardo Becerro‐de‐Bengoa‐Vallejo, Miguel A. Saavedra‐García, Daniel López‐López, Ana M. Jiménez‐Cebrián   +8 more
wiley   +1 more source

Coxitis in early axial spondyloarthritis

Современная ревматология, 2019
In Russia, coxitis is one of the most common extra-axial manifestations of ankylosing spondylitis (AS). However, many issues regarding its early diagnosis remain unresolved.Objective: to compare the clinical manifestations of coxitis with the data from ...
E. M. Agafonova, T. V. Dubinina, D. G. Rumyantseva, A. B. Demina, A. V. Smirnov, Sh. Erdes   +5 more
doaj   +1 more source

Flare risk after oral glucocorticoid bridging with methotrexate or intra‐articular bridging with triple therapy in early rheumatoid arthritis

Journal of Internal Medicine, Volume 299, Issue 6, Page 741-753, June 2026.
Abstract Objectives To investigate, in early rheumatoid arthritis, whether bridging with glucocorticoids (GCs) is associated with an increased risk of flare following GC tapering and withdrawal. Methods A total of 810 NOrdic Rheumatic Diseases Strategy Trials And Registries (NORD‐STAR) patients were included in this post hoc analysis: all received ...
Kristina Lend, Jos W. R. Twisk, Frieda A. Koopman, Anna Rudin, Merete Lund Hetland, Till Uhlig, Dan C. Nordström, Michael T. Nurmohamed, Bjorn Gudbjornsson, Kim Hørslev‐Petersen, Marte Schrumpf Heiberg, Tuulikki Sokka‐Isler, Gerdur Grondal, Espen A. Haavardsholm, Mikkel Østergaard, Jon Lampa, Ronald van Vollenhoven   +16 more
wiley   +1 more source

The role of magnetic resonance imaging in monitoring patients with axial spondyloarthritis

Introduction Axial spondyloarthritis (axSpA) comprises a group of chronic inflammatory joint diseases. Modern therapies enable the rapid achievement of low disease activity or even remission.
Rafał Wojciechowski
core   +1 more source

Axial spondyloarthritis in Latin America

, 2016
Latin American countries are often characterized by a significant miscegenation among whites, blacks, and Amerindians. These heterogeneous populations frequently represent a challenge for the design of studies analysing the genetics, incidence, and ...
Percival Sampaio-Barros, Rafael Valle-Oñate   +1 more
core   +1 more source

Novel therapies in axial spondyloarthritis.

, 2022
Over the past two decades, advancements in understanding the pathogenesis of axial spondyloarthritis have led to discoveries of new therapeutic targets, particularly the interleukin-17, tumor necrosis factor axis, and Janus kinase-signal transducer and ...
Bittar, Mohamad, Mease, Philip
core